In a mouse model of STZ-induced type 1 diabetes, we demonstrated SP1 activation in glomerular podocytes by showing increased immunostaining of Thr453-phosphorylated SP1 in podocyte nucleus, which was reversed by treating the animals with i.p. injections of MIT (Figure 2A). Here, SP1 is linked to type 1 diabetes mellitus.